Literature DB >> 26915499

Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial.

Steven A Narod1, Victoria Sopik2, Vasily Giannakeas3.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26915499     DOI: 10.1016/j.ygyno.2016.02.020

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  7 in total

1.  Ovarian cancer screening effectiveness: A realization from the UK Collaborative Trial of Ovarian Cancer Screening.

Authors:  Edward J Pavlik
Journal:  Womens Health (Lond)       Date:  2016-09-05

2.  Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens.

Authors:  Mohammad R Akbari; Shiyu Zhang; Deborah Cragun; Ji-Hyun Lee; Domenico Coppola; John McLaughlin; Harvey A Risch; Barry Rosen; Patricia Shaw; Thomas A Sellers; Joellen Schildkraut; Steven A Narod; Tuya Pal
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

3.  Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer.

Authors:  Felix Leung; Marcus Q Bernardini; Marshall D Brown; Yingye Zheng; Rafael Molina; Robert C Bast; Gerard Davis; Stefano Serra; Eleftherios P Diamandis; Vathany Kulasingam
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-07-22       Impact factor: 4.254

4.  Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.

Authors:  Paul A Cohen; Nicola Flowers; Stephen Tong; Natalie Hannan; Mark D Pertile; Lisa Hui
Journal:  BMC Med       Date:  2016-08-24       Impact factor: 8.775

5.  Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation.

Authors:  Ben Kearns; Jim Chilcott; Sophie Whyte; Louise Preston; Susi Sadler
Journal:  BMC Med       Date:  2016-12-06       Impact factor: 8.775

6.  Parenclitic networks for predicting ovarian cancer.

Authors:  Harry J Whitwell; Oleg Blyuss; Usha Menon; John F Timms; Alexey Zaikin
Journal:  Oncotarget       Date:  2018-04-27

7.  Novel gene signatures for prognosis prediction in ovarian cancer.

Authors:  Mingyang Bao; Lihua Zhang; Yueqing Hu
Journal:  J Cell Mol Med       Date:  2020-07-14       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.